 MINNEAPOLIS, July 28, 2021 PRNewswire -- Bio-Techne Corporation NASDAQ: TECH and PROGEN today announced the launch of the Simple PlexTM Adeno-Associated Virus AAV2 viral titer assay for AAV2 total capsid quantification. Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on EllaTM instruments, its multiplexing immunoassay system. 